Osteoporosis – Trends in Sequential Therapy
We recommend
Efficacy and Safety of Romosozumab in Postmenopausal Women with Osteoporosis and Renal Impairment
The coexistence of osteoporosis and chronic kidney disease (CKD) increases the risk of fractures and overall mortality in patients. A recent post-hoc analysis of two controlled randomized multicenter studies (FRAME and ARCH) investigated the efficacy and safety of romosozumab in postmenopausal women with osteoporosis and mild to moderate CKD.
Previous Treatment of Osteoporosis May Affect the Efficacy of Romosozumab
A study conducted by a team of authors from several clinical sites in Japan shows that the type and…
Can we properly manage osteoporotic fractures?
Osteoporotic fractures are associated with increased morbidity and mortality and often lead to an…
Articles on this topic
1
2
E-courses on this topic
Most read on this topic
- Can we properly manage osteoporotic fractures?
- Osteoporóza: nejčastější otázky a odpovědi
- Anabolic Antiosteoporotic Treatment as a First Step in Patients with Very High Fracture Risk
- Romosozumab vs. Teriparatide in Sequential Treatment of Osteoporosis in Women with a History of Fracture
- Inhibition of Sclerostin in Osteoporosis Therapy
- Rapid Strengthening and Long-term Stabilization – New Strategy for Sequential Treatment of Severe Osteoporosis
Journal on this topic
Related topic